The link between smoking status and co-morbid conditions in individuals with multiple sclerosis (MS)

Background In individuals with multiple sclerosis (MS) comorbidities and quality of life (QOL) may be affected by tobacco use. Objective To evaluate the associations between smoking status, in particular quit attempts, and comorbidities among individuals with MS. Methods We used a web-based survey t...

Full description

Saved in:
Bibliographic Details
Published in:Disability and health journal 2017-10, Vol.10 (4), p.587-591
Main Authors: Newland, Pamela, RN, PhD, CMSRN, Flick, Louise, DrPH, MSN, MPE, Salter, Amber, PhD, Dixon, David, PhD, Jensen, Mark P., Ph.D
Format: Article
Language:English
Subjects:
Adult
Cross-Sectional Studies
Depression - etiology
Disabled Persons
Female
Humans
Internal Medicine
Male
Middle Aged
Migraine Disorders - etiology
Multiple Sclerosis - psychology
Prevalence
Quality of Life
Smoking Cessation
Surveys and Questionnaires
Tobacco Smoking - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background In individuals with multiple sclerosis (MS) comorbidities and quality of life (QOL) may be affected by tobacco use. Objective To evaluate the associations between smoking status, in particular quit attempts, and comorbidities among individuals with MS. Methods We used a web-based survey to obtain cross-sectional data from 335 individuals with MS who were members of the Gateway Chapter of the National MS Society email registry. We then examined the associations between smoking variables (current use, frequency, and quit attempts) and comorbidities. Results The prevalence of participants who ever smoked was 50%, which is greater than that reported for the general population; 20% were current smokers. Migraine headaches were associated with current use and everyday smoking, and those with recent failed quit attempts had a higher prevalence of depression than those who were current smokers but who did not attempt to quit or had successfully quit in the past year. Conclusion Given the associations between smoking and comorbidities in individuals with MS, health care providers should both (1) assess smoking history and quit attempts, and (2) encourage individuals with MS who smoke to become non-smokers and refer for treatment, as indicated. In order to increase the chances that individuals will be successful in becoming non-smokers, clinicians would do well to also assess and treat depression in their patients who smoke and are also depressed.
ISSN:1936-6574
1876-7583
DOI:10.1016/j.dhjo.2017.03.005